The global nucleic acid isolation and purification market size is estimated to reach USD 9.77 billion by 2030, registering a CAGR of 9.61% from 2025 to 2030. The growth is attributed to the increasing number of cancer cases, chronic diseases prevalence, and rising public-private funding for biotechnology and life sciences research. In addition, advancements in automation and technology, and growing demand for genetically modified crops and organisms also contribute to the market growth. For instance, in December 2023, HiMedia Labs elaborated the significance and efficacy of magnetic bead-based systems in nucleic acid extraction and applying nucleic acid isolation and purification in various end-use industries.
The number of precision medicines developed for treating multiple diseases, such as diabetes, cancer, rheumatoid arthritis, neurological diseases, and autoimmune diseases. This market is introduced with the various new approaches, aiding the manipulation of genes. For instance, the companies are investing in a platform that delivers nucleic acids, such as small interfering RNAs (siRNAs), to address gene overexpression and mutations in conditions such as cancer, genetic disorders, and autoimmune diseases. Researchers are constantly trying to find effective therapeutics for patients. The upcoming new precision therapies may hold the key to treat incurable diseases. The use of nucleic acids and nucleic acid isolation & purification products and technologies are, therefore, very crucial for developing precision medicines.
The research and development (R&D) efforts in human genomics conducted by pharmaceutical and biotechnology companies have significantly transformed disease diagnosis and treatment development. The nucleic acid isolation and purification kits and instruments market is crucial in new drug discovery, target identification, and testing, particularly in genome editing. Substantial investments in R&D and drug discovery projects drive the competitive rivalry among companies in this space. The increasing adoption of emerging technologies for therapy development is expected to further drive market growth, with nucleic acid isolation and purification serving as a key step in manufacturing drugs and therapies through recombinant genetics. Key factors contributing to growth include the widespread use of CRISPR technology for identifying and validating therapeutics, creating improved animal testing models, and reducing the cost of research and development for drug discovery in preclinical trials.
The number of precision medicines developed for treating multiple diseases, such as diabetes, cancer, rheumatoid arthritis, neurological diseases, and autoimmune diseases. This market is introduced with the various new approaches, aiding the manipulation of genes. For instance, the companies are investing in a platform that delivers nucleic acids, such as small interfering RNAs (siRNAs), to address gene overexpression and mutations in conditions such as cancer, genetic disorders, and autoimmune diseases. Researchers are constantly trying to find effective therapeutics for patients. The upcoming new precision therapies may hold the key to treat incurable diseases. The use of nucleic acids and nucleic acid isolation & purification products and technologies are, therefore, very crucial for developing precision medicines.
The research and development (R&D) efforts in human genomics conducted by pharmaceutical and biotechnology companies have significantly transformed disease diagnosis and treatment development. The nucleic acid isolation and purification kits and instruments market is crucial in new drug discovery, target identification, and testing, particularly in genome editing. Substantial investments in R&D and drug discovery projects drive the competitive rivalry among companies in this space. The increasing adoption of emerging technologies for therapy development is expected to further drive market growth, with nucleic acid isolation and purification serving as a key step in manufacturing drugs and therapies through recombinant genetics. Key factors contributing to growth include the widespread use of CRISPR technology for identifying and validating therapeutics, creating improved animal testing models, and reducing the cost of research and development for drug discovery in preclinical trials.
Nucleic Acid Isolation And Purification Market Report Highlights
- Based on product, kits & reagents dominated the market with a largest revenue share in 2024, owing to the growing demand for kits for DNA/RNA extraction and purification.
- The instruments segment is expected to grow at a significant CAGR over the forecast period.
- Based on type, the DNA isolation and purification segment held the largest revenue share in 2024, owing to its variety of applications in the molecular biology field.
- The RNA isolation and purification segment is anticipated to witness a significant growth over the forecast period. The growth is attributed to its applications in gene expression profiling, sequencing, and clinical diagnostics.
- Based on application, the diagnostic segment led the market in 2024, owing to the rising application of DNA and RNA isolation for identifying pathogens in routine sample processing.
- The drug discovery & development segment is expected to grow at the significant CAGR over the forecast period, due to the increasing number of chronic diseases and other disorders.
- Based on method, the magnetic beads segment led the market in 2024. This can be attributed to its high efficacy and applications in a variety of fields.
- The column-based segment is expected to register a significant growth rate during the forecast period.
- Based on the end-use, the hospitals and diagnostics centers segment held the largest revenue share in 2024. The growth is due to the increased use of nucleic acid in a broad range of healthcare segments.
- The pharmaceutical and biotechnology companies segment is expected to register the fastest CAGR during the projected period.
- Based on region, North America dominated the global NAIP market, owing to factors such as leveraged government support, a favorable regulatory framework, and consistent R&D efforts.
- Asia Pacific is expected to grow at the fastest CAGR during the forecast period, due to several business initiatives undertaking in countries such as China, Japan, and India.
- In December 2023, Thermo Fisher Scientific Inc. launched an automatic nucleic acid purification instrument, Thermo Scientific KingFisher Apex Dx, and Applied Biosystems MagMAX Dx Pathogen/Viral NA Isolation Kit to isolate and purify bacterial and viral pathogens from biological samples.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This Report Addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Nucleic Acid Isolation And Purification Market Variables, Trends & Scope
Chapter 4. Product Business Analysis
Chapter 5. Type Business Analysis
Chapter 6. Application Business Analysis
Chapter 7. Method Business Analysis
Chapter 8. End Use Business Analysis
Chapter 9. Regional Business Analysis
Chapter 10. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- QIAGEN
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Danaher
- F. Hoffmann-La Roche Ltd
- Merck KGaA
- Agilent Technologies
- Bio-Rad Laboratories, Inc.
- Takara Bio Inc.
- Promega Corporation
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 135 |
Published | March 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 5.75 Billion |
Forecasted Market Value ( USD | $ 9.77 Billion |
Compound Annual Growth Rate | 9.6% |
Regions Covered | Global |
No. of Companies Mentioned | 10 |